BeOne Medicines (BEIGF) Cash from Investing Activities Growth (1y) (2016 - 2026)
BeOne Medicines (BEIGF) Cash from Investing Activities Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
62.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
62.68% |
| Dec 31, 2025 |
59.05% |
| Sep 30, 2025 |
63.20% |
| Jun 30, 2025 |
40.01% |
| Mar 31, 2025 |
41.89% |
| Dec 31, 2024 |
-49.57% |
| Sep 30, 2024 |
28.13% |
| Jun 30, 2024 |
-263.76% |
| Mar 31, 2024 |
-187.04% |
| Dec 31, 2023 |
-262.40% |
| Sep 30, 2023 |
-209.91% |
| Jun 30, 2023 |
-89.71% |
| Mar 31, 2023 |
14.58% |
| Dec 31, 2022 |
281.68% |
| Sep 30, 2022 |
1,512.96% |
| Jun 30, 2022 |
161.81% |
| Mar 31, 2022 |
-27.93% |
| Dec 31, 2021 |
75.60% |
| Sep 30, 2021 |
99.22% |
| Jun 30, 2021 |
158.52% |
